| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
No risks detected for 688198 from our risk checks.
Beijing Balance Medical Technology Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥107.38 |
| 52 Week High | CN¥144.00 |
| 52 Week Low | CN¥97.51 |
| Beta | 0 |
| 1 Month Change | -7.03% |
| 3 Month Change | 1.65% |
| 1 Year Change | -6.63% |
| 3 Year Change | 0.89% |
| 5 Year Change | n/a |
| Change since IPO | 324.91% |
Recent News & Updates
Shareholder Returns
| 688198 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 0.8% | 5.4% | 1.6% |
| 1Y | -6.6% | -16.4% | -15.1% |
Return vs Industry: 688198 exceeded the CN Medical Equipment industry which returned -21.5% over the past year.
Return vs Market: 688198 exceeded the CN Market which returned -16.2% over the past year.
Price Volatility
| 688198 volatility | |
|---|---|
| 688198 Average Weekly Movement | 7.1% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 688198 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688198's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 355 | Lei Jin | www.balancemed.cn |
Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patches; bovine pericardial valves, as well as pulmonary artery valved pipeline, outflow tract single flap patches, etc. Its products are used in heart valve replacement and repair, congenital heart disease implant intervention, and surgical soft tissue repair applications; and cardiothoracic surgery, neurosurgery, general surgery, and other surgical departments.
Beijing Balance Medical Technology Co.,Ltd. Fundamentals Summary
| 688198 fundamental statistics | |
|---|---|
| Market cap | CN¥14.67b |
| Earnings (TTM) | CN¥111.83m |
| Revenue (TTM) | CN¥382.01m |
131.1x
P/E Ratio38.4x
P/S RatioIs 688198 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688198 income statement (TTM) | |
|---|---|
| Revenue | CN¥382.01m |
| Cost of Revenue | CN¥38.28m |
| Gross Profit | CN¥343.74m |
| Other Expenses | CN¥231.91m |
| Earnings | CN¥111.83m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.82 |
| Gross Margin | 89.98% |
| Net Profit Margin | 29.27% |
| Debt/Equity Ratio | 0% |
How did 688198 perform over the long term?
See historical performance and comparison